171 related articles for article (PubMed ID: 18655139)
1. NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis.
Yamanaka Y; Abu-Amer W; Foglia D; Otero J; Clohisy JC; Abu-Amer Y
J Orthop Res; 2008 Dec; 26(12):1577-84. PubMed ID: 18655139
[TBL] [Abstract][Full Text] [Related]
2. Blockade of JNK and NFAT pathways attenuates orthopedic particle-stimulated osteoclastogenesis of human osteoclast precursors and murine calvarial osteolysis.
Yamanaka Y; Clohisy JC; Ito H; Matsuno T; Abu-Amer Y
J Orthop Res; 2013 Jan; 31(1):67-72. PubMed ID: 22847537
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin/NFAT pathway mediates wear particle-induced TNF-α release and osteoclastogenesis from mice bone marrow macrophages in vitro.
Liu FX; Wu CL; Zhu ZA; Li MQ; Mao YQ; Liu M; Wang XQ; Yu DG; Tang TT
Acta Pharmacol Sin; 2013 Nov; 34(11):1457-66. PubMed ID: 24056707
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts.
Abbas S; Clohisy JC; Abu-Amer Y
J Orthop Res; 2003 Nov; 21(6):1041-8. PubMed ID: 14554217
[TBL] [Abstract][Full Text] [Related]
5. Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts.
Yamanaka Y; Abu-Amer Y; Faccio R; Clohisy JC
J Orthop Res; 2006 Jul; 24(7):1349-57. PubMed ID: 16732613
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
[No Abstract] [Full Text] [Related]
7. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis.
Clohisy JC; Frazier E; Hirayama T; Abu-Amer Y
J Orthop Res; 2003 Mar; 21(2):202-12. PubMed ID: 12568950
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
10. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
[TBL] [Abstract][Full Text] [Related]
11. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
12. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
13. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
[TBL] [Abstract][Full Text] [Related]
14. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
15. Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells.
Kim EC; Park J; Noh G; Park SJ; Noh K; Kwon IK; Ahn SJ
Bioelectromagnetics; 2018 Jul; 39(5):394-404. PubMed ID: 29709064
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
17. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss.
Zhang L; Zhang L; You H; Sun S; Liao Z; Zhao G; Chen J
Eur J Pharmacol; 2021 Aug; 904():174176. PubMed ID: 34004213
[TBL] [Abstract][Full Text] [Related]
19. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
20. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
